Extracorporeal Therapy for Idiopathic Nephrotic Syndrome

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Novel therapeutic approaches for steroid-resistant nephrotic syndrome in paediatric patients: a comprehensive review

“…The role of circulating factors in the pathogenesis of nephrotic syndrome has generated considerable interest in extracorporeal therapies, including plasma exchange, immunoadsorption, and low-density lipoprotein apheresis. 6 Among the different extracorporeal treatments, plasma exchange (PE) therapy has been extensively researched and is the most commonly used intervention. 7 It has been postulated that PE therapy can quickly eliminate the permeability factor in the bloodstream, resulting in a reduction in proteinuria and an improvement in kidney function.…”